Benitec Biopharma to Participate in Upcoming Conferences in March
Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence ...
Tardigrade Protein Could Soon Make Cancer Patients More Radiation Proof
When people undergo radiotherapy for cancer, it's not just the tumor that suffers. The radiation causes DNA breaks in healthy ...
A protein from tiny tardigrades may help cancer patients tolerate radiation therapy
About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this ...
IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® ...
Nanoparticles deliver microRNAs to muscle stem cells for potential muscular dystrophy treatment
In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...
Korro to Present at the TD Cowen 45th Annual Health Care Conference
A live webcast of the presentation can be accessed on the “Events & Presentations” page in the Investor section of Korro’s website at www.korrobio.com. Following the presentation, a replay of the ...
Researchers spot a clue as to why human and mouse genomes overlap
Discovering ultra-conserved elements in the genome and their role in limiting protein production in mice testes.
‘Groundbreaking’ new vaccine REVERSES cancer in patients with ‘fatal disease’
A GROUNDBREAKING cancer vaccine reversed the disease in nine patients, a study has shown. They remained disease free three ...